These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6183349)

  • 1. Modulation of IL 2-dependent growth of mouse NK cells by interferon and T lymphocytes.
    Riccardi C; Vose BM; Herberman RB
    J Immunol; 1983 Jan; 130(1):228-32. PubMed ID: 6183349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partially restorative role of T cells for low interleukin 2 dependent growth of NK cell progenitors from nude mice.
    Riccardi C; Migliorati G; Herberman RB
    Nat Immun Cell Growth Regul; 1983-1984; 3(1):7-21. PubMed ID: 6235449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. II. Regulatory role of interferon on proliferative and cytotoxic precursors.
    Vose BM; Riccardi C; Bonnard GD; Herberman RB
    J Immunol; 1983 Feb; 130(2):768-72. PubMed ID: 6184405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones.
    Tsutsui H; Nakanishi K; Matsui K; Higashino K; Okamura H; Miyazawa Y; Kaneda K
    J Immunol; 1996 Nov; 157(9):3967-73. PubMed ID: 8892629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2-induced activation of natural killer activity in spleen cells from old and young mice.
    Saxena RK; Saxena QB; Adler WH
    Immunology; 1984 Apr; 51(4):719-26. PubMed ID: 6608487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.
    Suzuki R; Handa K; Itoh K; Kumagai K
    J Immunol; 1983 Feb; 130(2):981-7. PubMed ID: 6600260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
    Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T
    BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of low natural killer cell activity in infant and aged mice.
    Riccardi C; Giampietri A; Migliorati G; Frati L; Herberman RB
    Nat Immun Cell Growth Regul; 1986; 5(5):238-49. PubMed ID: 2946943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
    Bohn E; Autenrieth IB
    J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-induced inhibition of Moloney sarcoma virus-transformed cells: requirement for T-cells.
    Skicki-Mullen MB; Markovic SN; Murasko DM
    Cancer Res; 1989 Feb; 49(3):522-7. PubMed ID: 2463077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
    Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    Vose BM; Bonnard GD
    J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cells with natural killer activity in the cerebrospinal fluid of normal mice and athymic nude mice with acute Sindbis virus encephalitis.
    Griffin DE; Hess JL
    J Immunol; 1986 Mar; 136(5):1841-5. PubMed ID: 2419416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of spleen cell natural killer activity by thyroid hormone treatment in old mice.
    Provinciali M; Muzzioli M; Di Stefano G; Fabris N
    Nat Immun Cell Growth Regul; 1991; 10(4):226-36. PubMed ID: 1716738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of a gastrointestinal microflora on natural killer cell activity.
    Bartizal KF; Salkowski C; Balish E
    J Reticuloendothel Soc; 1983 May; 33(5):381-90. PubMed ID: 6341580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.